Login / Signup

CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt.

Ahmed ShawkyHussein SabitMahmoud NazihKhalid BarakaMokhtar El-Zawahry
Published in: Journal of epidemiology and global health (2023)
This study, along with other studies that address genotype variation of clopidogrel-metabolizing enzymes, might pave the way for further understanding of the pharmacogenetic background of CVD-related drugs.
Keyphrases